Wilms Joris
SEC insider (Form 3/4/5 filer). CIK 0001753231. SVP & CHIEF OPERATING OFFICER at Y-mAbs Therapeutics, Inc. (YMAB). 3 reported Form 4/5 transactions since Sep 2024; latest on Sep 16, 2025. Located in NEW YORK, NY.
Companies Wilms Joris has filed insider reports for
- Y-mAbs Therapeutics, Inc. (YMAB): Officer, SVP & CHIEF OPERATING OFFICER
Wilms Joris
CIK: 0001753231
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)2 (66.7%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
YMAB
Y-mAbs Therapeutics, Inc.
Officer